Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.77), $0.01 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• PG&E Corp, Edison spike on chatter
• Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'
• Anthropic launches Enterprise Frontier Safeguards for Claude